ProjectREVEAL-ACS – IIR, VDO031 (D1BVXAL02800), Geisler
Basic data
Acronym:
REVEAL-ACS
Title:
IIR, VDO031 (D1BVXAL02800), Geisler
Duration:
12/17/2015 to 12/31/2017
Abstract / short description:
Interventionelle "investigator initiated research" klinische Studie (IIR) zur Untersuchung des Effekts von Rivaroxaban auf Plättchenfunktion, Plättchen-vermittelte Gefäßentzündung, insbesodere auf die Thrombinerzeugung und deren intrazelluläre Mechanismen, bei ACS-Patienten verglichen mit der standard dualen antiplatelet Therapie (DAPT) ex vivo (Teil 1) und in vivo (Teil 2)
Keywords:
ACS
dual antiplatelet therapy
rivaroxaban
NSTEMI
platelet function
thrombin
Involved staff
Managers
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Internal Medicine Department III
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Leverkusen, Nordrhein-Westfalen, Germany